Mobidiag: Hologic to Acquire Molecular Diagnostic Company Mobidiag
Hologic has signed a definitive agreement to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million.
Read full article »
Mobidiag is a Finland-based biotechnology company that manufactures and commercialization of vaccine products for the prevention and treatment of infectious diseases.
Read more